Hours after trainer Bob Baffert announced that 2021 Kentucky Derby winner Medina Spirit tested positive for excessive amounts of an anti-inflammatory drug, the Maryland Jockey Club said it is reviewing the colt’s status for Saturday’s Preakness Stakes.
“We are consulting with the Maryland Racing Commission and any decision regarding the entry of Medina Spirit in the 146th Preakness Stakes will be made after review of the facts,” the MJC said in a release.
Baffert said Sunday he is moving ahead with plans to start both Concert Tour and Medina Spirit in the Grade 1, $1 million Preakness. He has won the Triple Crown’s middle jewel six times, most recently with Justify in 2018.
The full MJC statement reads below:
“Integrity in the sport of Thoroughbred horse racing is the ultimate priority for 1/ST RACING and the Maryland Jockey Club (MJC). 1/ST RACING has been an industry leader instituting processes and protocols that have led to nationwide medication reform and increased accountability. We are committed to achieving the highest level of horse care and safety standards, and we have a proven track record of pushing those standards forward.
“1/ST RACING and MJC intend to review the relevant facts and information relating to the reported medication positive as a result of the post-race blood sample testing completed by Churchill Downs following the 147th Kentucky Derby involving Medina Spirit trained by Bob Baffert. We are consulting with the Maryland Racing Commission and any decision regarding the entry of Medina Spirit in the 146th Preakness Stakes will be made after review of the facts.”